​

Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast

Medtronic (MDT) stock forecast, based on 47 Wall Street analysts, predicts a 12-month average price target of $93.00, with a high of $93.00 and a low of $93.00. This represents a 12.45% increase from the last price of $82.70.

$75 $79 $83 $87 $91 $95 High: $93 Avg: $93 Low: $93 Last Closed Price: $82.7

MDT Stock Rating

Medtronic stock's rating consensus is Buy, based on 47 Wall Street analysts. The breakdown includes 1 Strong Buy (2.13%), 25 Buy (53.19%), 21 Hold (44.68%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 47 21 25 1 Strong Sell Sell Hold Buy Strong Buy

MDT Price Target Upside V Benchmarks

TypeNameUpside
StockMedtronic12.45%
SectorHealthcare Stocks 33.91%
IndustryMedical Device Stocks20.97%

Price Target Trends

1M3M12M
# Anlaysts--16
Avg Price Target--$94.94
Last Closing Price$82.70$82.70$82.70
Upside/Downside--14.80%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25511141132
Mar, 25410151131
Feb, 25410151131
Jan, 25511151133
Dec, 24611141133
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 08, 2025Lee HambrightBernstein$93.00$82.6812.48%12.45%
Oct 15, 2024David RescottRobert W. Baird$96.00$90.016.65%16.08%
Oct 10, 2024Shagun SinghRBC Capital$105.00$88.3518.85%26.96%
Oct 01, 2024Vijay KumarEvercore ISI$104.00$90.0315.52%25.76%
Oct 01, 2024Joanne WuenschCitigroup$92.00$90.032.19%11.25%
Aug 21, 2024David RomanGoldman Sachs$82.00$86.40-5.09%-0.85%
Aug 21, 2024Steven LichtmanOppenheimer$94.00$86.468.72%13.66%
Aug 21, 2024Matt O'BrienPiper Sandler$90.00$85.385.41%8.83%
Aug 21, 2024Anthony PetroneMizuho Securities$98.00$86.3813.45%18.50%
Aug 21, 2024Larry BiegelsenWells Fargo$106.00$85.3824.15%28.17%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 04, 2025CitigroupNeutralBuyupgrade
Jan 08, 2025BernsteinOutperformOutperformhold
Nov 19, 2024NeedhamHoldHoldhold
Oct 10, 2024RBC CapitalSector PerformOutperformupgrade
Oct 08, 2024Wells FargoSector PerformSector Performhold
Oct 08, 2024RBC CapitalSector PerformSector Performhold
Oct 01, 2024Evercore ISIOutperformOutperformhold
Oct 01, 2024CitigroupNeutralNeutralhold
Sep 12, 2024Piper SandlerNeutralNeutralhold
Aug 22, 2024BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$3.57$2.68$3.75$2.83$2.77-----
Avg Forecast$4.98$4.36$5.66$5.27$5.20$5.45$5.84$6.30$6.85$7.36
High Forecast$5.03$4.40$5.72$5.33$5.23$5.47$5.88$6.65$6.92$7.44
Low Forecast$4.93$4.31$5.60$5.22$5.19$5.44$5.76$4.95$6.78$7.29
Surprise %-28.31%-38.53%-33.75%-46.30%-46.73%-----

Revenue Forecast

$25B $29B $33B $37B $41B $45B Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$28.91B$30.12B$31.69B$31.23B$32.36B-----
Avg Forecast$29.68B$30.06B$32.02B$30.94B$32.22B$33.57B$35.14B$36.89B$39.10B$41.02B
High Forecast$29.92B$30.30B$32.28B$31.25B$32.26B$33.65B$35.36B$36.91B$39.42B$41.35B
Low Forecast$29.45B$29.82B$31.76B$30.63B$32.16B$33.47B$34.94B$36.88B$38.79B$40.70B
Surprise %-2.60%0.20%-1.05%0.94%0.44%-----

Net Income Forecast

$3B $4B $6B $7B $9B $10B Apr 20 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 20Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$4.79B$3.61B$5.04B$3.76B$3.68B-----
Avg Forecast$4.47B$3.56B$4.39B$7.02B$4.29B$7.26B$7.74B$7.72B$9.11B$9.79B
High Forecast$5.37B$4.28B$5.27B$7.09B$5.15B$7.28B$7.82B$8.85B$9.21B$9.90B
Low Forecast$3.58B$2.85B$3.51B$6.94B$3.43B$7.24B$7.66B$6.58B$9.02B$9.70B
Surprise %7.10%1.18%14.78%-46.43%-14.27%-----

MDT Forecast FAQ

Is Medtronic stock a buy?

Medtronic stock has a consensus rating of Buy, based on 47 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 25 Buy, 21 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medtronic is a favorable investment for most analysts.

What is Medtronic's price target?

Medtronic's price target, set by 47 Wall Street analysts, averages $93 over the next 12 months. The price target range spans from $93 at the low end to $93 at the high end, suggesting a potential 12.45% change from the previous closing price of $82.7.

How does Medtronic stock forecast compare to its benchmarks?

Medtronic's stock forecast shows a 12.45% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the medical device stocks industry (20.97%).

What is the breakdown of analyst ratings for Medtronic over the past three months?

  • April 2025: 15.62% Strong Buy, 34.38% Buy, 43.75% Hold, 3.12% Sell, 3.12% Strong Sell.
  • March 2025: 12.90% Strong Buy, 32.26% Buy, 48.39% Hold, 3.23% Sell, 3.23% Strong Sell.
  • February 2025: 12.90% Strong Buy, 32.26% Buy, 48.39% Hold, 3.23% Sell, 3.23% Strong Sell.

What is Medtronic’s EPS forecast?

Medtronic's average annual EPS forecast for its fiscal year ending in April 2025 is $5.45, marking a 96.75% increase from the reported $2.77 in 2024. Estimates for the following years are $5.84 in 2026, $6.3 in 2027, $6.85 in 2028, and $7.36 in 2029.

What is Medtronic’s revenue forecast?

Medtronic's average annual revenue forecast for its fiscal year ending in April 2025 is $33.57B, reflecting a 3.74% increase from the reported $32.36B in 2024. The forecast for 2026 is $35.14B, followed by $36.89B for 2027, $39.1B for 2028, and $41.02B for 2029.

What is Medtronic’s net income forecast?

Medtronic's net income forecast for the fiscal year ending in April 2025 stands at $7.26B, representing an 97.45% increase from the reported $3.68B in 2024. Projections indicate $7.74B in 2026, $7.72B in 2027, $9.11B in 2028, and $9.79B in 2029.